Bridgefront Capital’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,047
| Closed | -$138K | – | 376 |
|
|
2023
Q3 | $138K | Sell |
21,047
-2,460
| -10% | -$16.1K | 0.1% | 344 |
|
|
2023
Q2 | $191K | Buy |
23,507
+3,175
| +16% | +$25.8K | 0.1% | 391 |
|
|
2023
Q1 | $174K | Buy |
+20,332
| New | +$174K | 0.11% | 359 |
|
|
2022
Q4 | – | Sell |
-10,214
| Closed | -$105K | – | 366 |
|
|
2022
Q3 | $105K | Buy |
+10,214
| New | +$105K | 0.11% | 274 |
|